demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only
COVID-19 severe or critically
COVID-19 (hospitalized or not)
anti-inflammatoty and immuno-therapy
corticosteroids Husain
Immunostimulants drugs
levamisole Roostaei
Immunosuppressants drugs
anti-interleukin-6
tocilizumab Hong Zhao

5 studies excluded by filtering options 1

5319 Wu, 2020 1133not a RCThigh risk of bias
5568 Zhang, 2020 0130selection pending
5615 Nelson (Methylprednisolone), 2020 0130selection pending
6036 Esba, 2020 0100selection pending
6048 Wu, 2020 0110selection pending